Ultragenyx Pharmaceutical Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 05/08/2026 | Mar 2026Filed 06/05/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 05/08/2026 | Mar 2025Filed 06/05/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 06/08/2025 | Mar 2024Filed 07/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $214 | $136 | $160 | $167 | $139 | $139 | $147 | $109 | |
| −$92 | −$185 | −$180 | −$115 | −$151 | −$134 | −$132 | −$171 | |
| −$0.90 | −$1.84 | −$1.81 | −$1.17 | −$1.57 | −$1.40 | −$1.52 | −$2.03 | |
| 102 | 101 | 100 | 99 | 96 | 95 | 87 | 84 |
Trend